entry for STT, pxs pharmaceutical comapny current price 12.5c market cap 39 million ever low price 4.5 dollars around 2008 cash around 51 million elects to recieve 40 million from novaquest for future trials and royalities fda explation pending for failing clinical trial 3 lot of discussions going with majors for future research and prospects revenue generating company in australia and europe major drus bronchitol and aridol sales increasing every quarter excellent management recommendation from deucthe bank for 71 c if im not mistaken after failed approval from FDA huge volume and weird trading lately australian ethical fund the number 1 rated fund in australai became a substantial holder last couple of weeks director bought yesterday on market my target short term 28c cheers
